We are committed to protecting the privacy and confidentiality of our website users' personal information. Our Privacy Policy outlines the measures we take to ensure the secure handling and protection of any data provided through our website, including:

Collection and use of personal information for the sole purpose of evaluating eligibility for the Targeted Osmotic Lysis (TOL) pilot study.

Implementation of industry-standard security measures to safeguard personal information from unauthorized access, disclosure, or misuse.

Strict adherence to data privacy laws and regulations, including the Health Insurance Portability and Accountability Act (HIPAA).

Clear disclosure of the types of personal information collected, how it is used, and the circumstances under which it may be shared with third parties.

Providing users with the ability to access, update, or delete their personal information upon request.

As a healthcare-related website, we are committed to complying with the Health Insurance Portability and Accountability Act (HIPAA) regulations to protect the privacy and security of protected health information (PHI). Our website and data handling practices adhere to HIPAA guidelines, including:

Implementing administrative, physical, and technical safeguards to ensure the confidentiality, integrity, and availability of PHI.

Obtaining appropriate authorizations and consent from patients before using or disclosing their PHI for treatment, payment, or healthcare operations.

Restricting access to PHI only to authorized personnel who require it for legitimate purposes.

Providing patients with their rights regarding their PHI, including the right to access, amend, and receive an accounting of disclosures.

Training our staff on HIPAA compliance and maintaining strict confidentiality policies.

Reporting and mitigating any potential breaches of PHI in accordance with HIPAA breach notification rules.

Assurance of compliance with HIPAA regulations